WebAbstract. Introduction: Gemcitabine and cisplatin is the standard first-line systemic treatment in patients with advanced cholangiocarcinoma (CCA). However, a substantial number of patients do not qualify for cisplatin due to comorbidities or poor performance status. The phase II pilot study NACHO evaluated the efficacy of nab-paclitaxel (125 … WebJul 28, 2024 · Cisplatin is a heavy metal compound that inhibits synthesis of RNA, DNA, and protein in cells. All of these compounds are vital for cells to divide and grow. By …
Radial radiokjemoterapi ved lokalregional sykdom i …
WebApr 3, 2014 · Cisplatin, a widely used cancer treatment, causes marked hearing loss in over 75% of the nearly 700000 patients treated each year. See www.otologicpharmaceutic.com for additional information about HPN1010. About Accele Biopharma, Inc. WebThis exposure to cisplatin results in a range of toxicities . In addition, circulating …. Prevention of chemotherapy-induced nausea and vomiting in adults. …remains necessary, at least in patients receiving cisplatin -based chemotherapy. This was illustrated by a randomized trial in which patients receiving cisplatin chemotherapy were ... can my spouse enroll in my employer\u0027s fsa
Monitoring response to cytostatic cisplatin in a HER2(+) ovary …
WebSep 15, 2024 · Cisplatin is a prescription medicine used to treat the symptoms of cancer in the testicles (Metastatic Testicular Tumors), bladder (Advanced Bladder Cancer) and … Cisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. It is given by injection into a vein. Common side … See more Cisplatin is administered intravenously as short-term infusion in normal saline for treatment of solid and haematological malignancies. It is used to treat various types of cancers, including sarcomas, some See more Cisplatin is the square planar coordination complex cis-[Pt(NH3)2Cl2]. The prefix cis indicates the cis isomer in which two similar ligands are in adjacent positions. The systematic … See more Syntheses of cisplatin start from potassium tetrachloroplatinate. Several procedures are available. One obstacle is the facile formation of See more Cisplatin has a number of side effects that can limit its use: • Nephrotoxicity (kidney damage) is the primary dose-limiting side effect and is of major clinical concern. Cisplatin selectively accumulates into the proximal tubule via basolateral-to … See more Cisplatin interferes with DNA replication, which kills the fastest proliferating cells, which in theory are cancerous. Following administration, one chloride ion is slowly displaced by water … See more The compound cis-[Pt(NH3)2Cl2] was first described by Italian chemist Michele Peyrone in 1845, and known for a long time as Peyrone's … See more Cisplatin has been studied with Auger therapy to increase the therapeutic effects of cisplatin, without increasing normal tissue toxicities. See more WebMay 1, 2024 · Cisplatin remains a cornerstone for treating NSCLC, however little is known about the mechanisms of resistance associated with changes in cell’s metabolism. In this work, using cell models, PDX models and biopsies of patients with NSCLC, we have analyzed the metabolic changes produced by cisplatin treatment. In addition, taking … can neck issues affect vision